FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

18664511000001102: Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-May 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
63946201000001112 Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
63946301000001115 Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets Is a Tapentadol 150mg modified-release tablets 56 tablet true Inferred relationship Existential restriction modifier
Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets Has AMP Palexia SR 150mg tablets (Grunenthal Ltd) true Inferred relationship Existential restriction modifier
Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets Has specific active ingredient Tapentadol hydrochloride true Inferred relationship Existential restriction modifier
Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tapentadol true Inferred relationship Existential restriction modifier
Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Palexia SR 150mg tablets (Grunenthal Ltd) 56 tablet 8 x 7 tablets Has basis of strength substance Tapentadol true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start